Boehringer Ingelheim RCV GmbH & Co KG
(Associate) Principal Scientist (f/m/d) - Translational Medicine and Clinical Pharmacology
- 1120 Wien
- Vollzeit
- Bereichsleitung
- ab 68.000,00 €
Anfahrtszeit h
1120 Meidling
At Boehringer Ingelheim we develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, we focus on long-term performance. We believe that, if we have talented and ambitious people who are passionate about innovation, there is no limit to what we can achieve; after all, we started with just 28 people. Now, we are powered by 50,000 employees globally who nurture a diverse, collaborative and inclusive culture.
We are seeking a motivated and results-oriented (Associate) Principal Scientist to join our global Translational Medicine and Clinical Pharmacology team in Vienna. This position will strengthen our multi-disciplinary team, focused on translational and biomarker-related aspects of pre-clinical drug development for patients with cancer. It offers a unique opportunity to work at the forefront of the development of novel cancer therapies, with a specific focus on immunotherapeutic agents.
The remuneration for this position starts at EUR 68.000 gross annual salary (full time) as well as a variable bonus. When defining the actual salary we are taking your technical skills as well as personal competencies and relevant professional experience into consideration. We will be happy to discuss further details in person.
By uploading your application documents via our application portal, we can treat your data confidentially and in compliance with the GDPR.
Do you have any additional questions about the position? Your HR Recruiting Manager for this position is Kerstin Kornfeld.
On our career site you will find further interesting information about us as an employer as well as information about the application process or our diverse divisions. Take a look behind the scenes and get an insight into our day-to-day business.